CO
Publicaties op Oncologisch.com
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Rece...
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant...
FDA-goedkeuring van capivasertib plus fulvestrant bij mammacarcinoom
FDA-goedkeuring van T-DXd bij HER2-laag mammacarcinoom